“Evidence for the Conversion of Docetaxel into 7-Epidocetaxel in Patients Receiving Conventional Taxotere® Based Chemotherapy”. Journal of Analytical Oncology, vol. 3, no. 2, Apr. 2014, pp.  73-78, https://doi.org/10.6000/1927-7229.2014.03.02.1.